Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

ISC THERAPY FAQ

Home ISC ISC THERAPY FAQ
ISC THERAPY

Frequently Asked Questions

Immune Signaling Cells (ISC) therapy is an autologous immuno-regulating cellular therapy aimed at regulating the immune system responsible for the healing process in our body. It is the ONLY cell therapy that is covered by a medical insurance policy, reflecting its high safety profile.

Immune Signaling Cells (ISC) provides the key to regulate our immune system that controls the inflammatory response and tissue repairment. Advancing the regulation and management of inflammation not only strengthen our body’s defending power against foreign invaders but it also enhances the wound healing process to achieve a quicker and better recovery of body function and health.

ISC is used for balancing the immune system and inflammatory conditions, such as:

  • Autoimmune condition
  • Immunodeficiency condition
  • Inflammatory conditions
  • Cardiovascular diseases
  • Allergy
  • Post-chemotherapy / Post-radiation therapy
  • Diabetes management
  • Chronic wound
  • Sport injury

Each ISC treatment is about 4-5 days. During the treatment period, the patient will undergo a pre-treatment health exam, blood collection for ISC processing, precondition therapy, and ISC infusion.

Day 1/Day 2: Pre-treatment examination and 250ml blood collection (1hr)

Day 5: ISC intravenous infusion (1hr)

ISC cellular product is cultured from the recipient’s blood and is reinfused all back to the patient on the third or fourth day after the blood collection.

For full treatment program >

The number of treatments needed will depend on the type and severity of the disease, individual’s health condition and a comprehensive assessment by your treating doctor to design your personalized treatment plan.Usually, we will recommend one treatment every 1-3 years for disease prevention and optimum health.

For chronic disease patient, a more intensive treatment plan may be required according to the health assessment review. In such cases, the patient might need to undergo 2-3 times of ISC treatment during the first 6 months and follow-up treatments based on the previous treatment results.

Generally, the patient will experience overall improved energy level, sleep quality and immunity improvement within one month after the treatment.

Chronic pain relief could be experienced within a short period as the result of anti-inflammatory effect from the ISC therapy. However, some might take longer to experience the change as the cause of pain required time to repair the injury and regenerate the lost cells.

Post-chemo, radiation and surgery wound usually require 1-2 months for cell regrowth, tissue reconstruction and organ function recovery (partial). However, cell regeneration and tissue repair could take place without being indicated at specific parts of the body, but in the cellular level and systemic aspect. We look at the holistic point of view to optimize the immune regulation and metabolism process: for treating the entire body’s physiological balance: Homeostasis.

*ISC Therapy is a personalized treatment, the general observation and results are only for reference, not applicable to every case.

In general, the patient will experience:

  • Better sleep quality: less urine at night, deeper sleep
  • Overall energy level increase
  • Stronger immunity: less getting cold, better defense against foreign pathogen
  • Better healing ability: quicker recovery after injury, surgery or any event resulting in an open wound, and shorten the repair period
  • “Optimize inflammatory regulation”: the underlying root factor for all the above advantages.

ISC cellular therapy has an AUD20-million-indemnity life science insurance and with more than 200 cases of clinical cases conducted with no adverse effects reported.

A high standard cell manufacturing environment and strict production protocol give the most basic and essential criteria for quality control. A third-party sterile test of every sample gives the extra guarantee of quality and safety assurance.

Bruising at the blood collection point, slightly fatigue or electrolytes imbalance might occur due to the extraction of 250ml peripheral blood in the first 24 hours after blood collection. Ensuring that you have a good rest, stay hydrated and electrolytes replacement could relieve the symptoms efficiently. Acute inflammation (stronger pain at the point of injury), slightly increasing of body temperature and fatigue might be experienced in the first 3 to 7 days after the ISC infusion. Pain relief could be taken to ease the pain if required; however, the type of pain relief has to be non-anti-inflammatory. Alcohol and anesthetic medication should be avoided during the first week after the infusion. Proper rest, a healthy diet and regular exercise are highly recommended to improve the treatment results.

Global Locations

Visit us at our international medical centres for a free consultation.

AUSTRALIA
Brisbane
THAILAND
Bangkok
CHINA
Beijing
INDONESIA
Jakarta

Book Consultation